Journal Menu
► ▼ Journal Menu-
- Current Oncology Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Editorial Office
- 30th Anniversary
Journal Browser
► ▼ Journal Browser-
arrow_forward_ios
Forthcoming issue
arrow_forward_ios Current issue - Volumes not published by MDPI
Need Help?
Announcements
24 November 2021
Current Oncology | New Section “Cell Therapy” Established
We are pleased to announce a new Section in Current Oncology (ISSN: 1718-7729), entitled “Cell Therapy”, to provide a specific venue for this research.
The Section will cover basic, translational, and clinical research on all aspects related to cell therapy and transplantation in the treatment of cancer. This includes:
- conventional hematopoietic cell transplantation and associated novel insights, innovations, and new enabling technologies that can improve patient outcomes;
- immune effector cell therapies to treat cancer, such as chimeric-antigen receptor T or NK cell therapy or tumor-infiltrating cell-based approaches;
- identifying, collecting, and manufacturing cell products will also be considered favorably, particularly if related to clinical cancer outcomes.